
RANI P/E Ratio
P/E Ratio as of Oct 28, 2025: -2.08
Average-1.18
Median-0.5600
Minimum-3.13
Maximum-0.5000
-2.08
Past Month-1.55 (292.45%)
The P/E ratio for RANI is -2.08 as of Oct 28, 2025. This represents a increase of 94.39% compared to its 12-month average P/E ratio of -1.07. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Rani Therapeutics Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Rani Therapeutics Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Rani Therapeutics Holdings to industry peers.
Rani Therapeutics Holdings P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Rani Therapeutics Holdings’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Rani Therapeutics Holdings to industry peers.
RANI P/E Ratio Insights
See Rani Therapeutics Holdings’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in RANI
Order type
Buy in
Order amount
Est. shares
0 shares
RANI P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2025 | $0.509 | -0.56 |
| Sep 2, 2025 | $0.466 | -0.51 |
| Aug 1, 2025 | $0.5284 | -0.54 |
| Jul 1, 2025 | $0.5135 | -0.52 |
| Jun 2, 2025 | $0.557 | -0.57 |
| May 1, 2025 | $1.07 | -1.01 |
| Apr 1, 2025 | $1.23 | -1.17 |
| Mar 3, 2025 | $1.47 | -1.39 |
| Feb 3, 2025 | $1.36 | -1.29 |
| Jan 2, 2025 | $1.46 | -1.38 |
RANI End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -2.08 | +60.00% |
| 2024 | -1.30 | -44.68% |
| 2023 | -2.35 | -52.53% |
| 2022 | -4.95 | -70.20% |
| 2021 | -16.61 | — |
FAQs About Rani Therapeutics Holdings (RANI) P/E ratio
The latest P/E ratio of RANI is -2.08, as of Oct 28, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Rani Therapeutics Holdings’s last 12-month average P/E ratio is -1.07, compared to its current P/E ratio of -2.08. This reflects a increase of 94.39%.
Rani Therapeutics Holdings’s current P/E ratio of -2.08 is higher than its last 12-month average P/E of -1.07. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Rani Therapeutics Holdings’s average P/E ratio over the last 3 years is -2.56. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Rani Therapeutics Holdings’s average P/E ratio over the last 5 years is -4.01. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.